3,4-dihydroxybenzohydroxamic acid has been researched along with Pulmonary Fibrosis in 1 studies
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tryka, AF | 1 |
1 other study available for 3,4-dihydroxybenzohydroxamic acid and Pulmonary Fibrosis
| Article | Year |
|---|---|
ICRF 187 and polyhydroxyphenyl derivatives fail to protect against bleomycin induced lung injury.
Topics: 2,4-Dichlorophenoxyacetic Acid; Animals; Bleomycin; Cricetinae; Free Radicals; Hydroxamic Acids; Iro | 1989 |